From the Editor

The Five-Take Home Messages of the LATITUDE and STAMPEDE Studies - Charles Ryan

Charles Ryan
November 21, 2017

Brief high-level review of the LATITUDE and STAMPEDE Studies

LATITUDE was a phase III trial of men with high-volume metastatic prostate cancer (PC) that had not been previously treated with androgen deprivation therapy (ADT).1 The patients were randomized to receive standard ADT with placebos vs. ADT plus abiraterone and prednisone. The primary endpoint is overall survival (OS).

READ MORE PREVIOUS ARTICLES

Dr. Charles J. Ryan, MD

Charles J. Ryan, MD

Charles J. Ryan, MD is Professor of Clinical Medicine and Urology and the Clinical Program Leader for Genitourinary Medical Oncology at the UCSF Helen Diller Family Comprehensive Cancer Center. He received his MD from the University of Wisconsin in Madison and completed his residency in internal medicine at the University of Wisconsin Hospital and Clinics, where he also served as Chief Resident. He completed a fellowship in medical oncology in the Department of Medicine at Memorial Sloan-Kettering Cancer Center and the Joan and Sanford I. Weill Medical College of Cornell University in New York.

Video Lectures
State-of-the-industry video lectures by leading urology experts
@UroToday